Thomas Hardmeier
Impact in
-
- Vascular Tumors and Angiosarcomas
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
-
- Eosinophilic Disorders and Syndromes
Papers in
- Oncology 4
- COVID-19 and healthcare impacts 1
- Cutaneous Melanoma Detection and Management 1
-
- Cardiac electrophysiology and arrhythmias 1
- Cardiac Arrhythmias and Treatments 1
- Cardiac pacing and defibrillation studies 1
- Cardiac tumors and thrombi 1
- Co-authors
- Michael J. Flaig (1 shared paper)Beatrix Mueller (1 shared paper)Renato G. Panizzon (1 shared paper)Günter Burg (1 shared paper)A Haeffner (1 shared paper)Christian A. Sander (1 shared paper)Volker Adams (1 shared paper)Karoline Zepter (1 shared paper)
- Journals
- Human Pathology (1 paper)International Journal of Cancer (1 paper)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (1 paper)The Journal of Pathology Clinical Research (1 paper)International Journal of Legal Medicine (1 paper)
- Partner nations
- SwitzerlandGermanyBelgium
In The Last Decade
Thomas Hardmeier
6 papers receiving 177 citations
Peers
Comparison fields: 5 of 38
- Oncology 149
- Rheumatology 55
- Dermatology 28
- Cardiology and Cardiovascular Medicine 32
- Pathology and Forensic Medicine 19
Countries citing papers authored by Thomas Hardmeier
This map shows the geographic impact of Thomas Hardmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hardmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hardmeier more than expected).
Fields of papers citing papers by Thomas Hardmeier
This network shows the impact of papers produced by Thomas Hardmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hardmeier. The network helps show where Thomas Hardmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Hardmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 81 | |
| 2 | 1996 | 77 | |
| 3 | 2020 | 23 | |
| 4 | 1984 | 8 | |
| 5 | 2004 | 2 | |
| 6 | 1973 | 2 |
About Thomas Hardmeier
Thomas Hardmeier is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Infectious Diseases, Genetics and Pathology and Forensic Medicine, having authored 6 papers that have together received 193 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Cardiac Arrhythmias and Treatments (1 paper), COVID-19 and healthcare impacts (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Cutaneous Melanoma Detection and Management (1 paper), Cardiac pacing and defibrillation studies (1 paper) and Cardiac tumors and thrombi (1 paper). The work is most often cited by research in Oncology (149 citations), Rheumatology (55 citations), Dermatology (28 citations), Cardiology and Cardiovascular Medicine (32 citations) and Pathology and Forensic Medicine (19 citations). Thomas Hardmeier has collaborated with scholars based in Switzerland, Germany and Belgium. Frequent co-authors include Michael J. Flaig, Beatrix Mueller, Renato G. Panizzon, Günter Burg, A Haeffner, Christian A. Sander, Volker Adams, Karoline Zepter, Werner Kempf and Christian De Potter. Their work appears in journals such as Human Pathology, International Journal of Cancer, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, The Journal of Pathology Clinical Research and International Journal of Legal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.